Lmr Partners LLP Deciphera Pharmaceuticals, Inc. Transaction History

Lmr Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$9.11 - $13.98 $965,659 - $1.48 Million	-106,000 Reduced 83.9%	20,335 $267,000
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $480,900 - $777,700	-70,000 Reduced 35.65%	126,335 $1.17 Million
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $1.12 Million - $5.38 Million	145,000 Added 282.46%	196,335 $1.92 Million
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $1.36 Million - $1.91 Million	51,335 New	51,335 $1.74 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.